Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program.

@article{Gray2017EffectivenessOI,
  title={Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program.},
  author={Emma Gray and Aisling O'Leary and Colm J Bergin and Mary Cannon and Garry Courtney and Orla Crosbie and C De Gascun and Liam J Fanning and Eoin R. Feeney and Diarmaid Dominic Houlihan and Barry Kelleher and John S Lambert and John C. M. Lee and Pwg Mallon and Shaun Mcconkey and Aidan McCormick and S Mckiernan and Cora McNally and Frank E. Murray and Gerard J Sheehan and Stephen F Stewart and Cathal Walsh and Suzanne Norris},
  journal={Expert review of gastroenterology & hepatology},
  year={2017},
  volume={11 6},
  pages={
          593-601
        }
}
BACKGROUND We investigated the real-world effectiveness of interferon-free regimens for the treatment of patients with compensated cirrhosis infected with hepatitis C virus (HCV). METHOD Using the Irish national HCV treatment registry, the effectiveness and safety of interferon-free regimens for HCV-infected patients treated between April 2015 and August 2016, was determined. RESULTS A SVR12 was achieved in 86% of subjects treated with sofosbuvir/ledipasvir ± ribavirin (SOF/LDV±RBV), 93… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES